Feb 7, 2022 | Letters Submitted
We have serious concerns about CMS’s draft national coverage determination (NCD) – issued January 11, 2022 – to limit Medicare coverage for monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s Disease (AD) to patients enrolled in...
Read more
Feb 22, 2020 | Copay Accumulators, Copay Assistance, Drug Costs, Federal Issues, News
Patients struggling with the high cost of health insurance can expect even higher out-of-pocket costs in 2021, under an insurance regulation proposed by the Centers for Medicare & Medicaid Services. Last month, the obscure federal agency under the Department of...
Read more
Sep 9, 2019 | Copay Accumulators, Drug Costs, News, Out of Pocket Costs
Get ready for higher out-of-pocket costs in 2020. Last week, the Trump administration’s Centers for Medicare & Medicaid Services quietly announced new co-pay rules that will allow insurance companies to increase patients’ out-of-pocket costs in 2020....
Read more
